Our Landmarks of OncoPharm series returns to talk about 2008's VISTA study, which ushered bortezomib into the front line setting, albeit with a now outdated alkylating agent-based backbone.
VISTA (VMP vs. MP): https://www.nejm.org/doi/full/10.1056/nejmoa0801479
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More